Market Snapshot

S&P Futures
Dow Futures
NASDAQ Futures

43.94$-0.25 -0.57 %
At close       04:00 PM    

Stock Snapshot

44.19
Prev. Close
44.07
Open
247.76B
Market Cap
61.42M
Number of Shares
43.81
Day Low
44.41
Day High
43.94
18.76
P/E Ratio
-
Free Float in %
2.34
EPS 2021
12.51
Book Value per Share
3.85
Cash Flow per Share
Pfizer Inc. (PFE)
Pfizer Inc. (PFE) stock rallied over -0.57% intraday to trade at $43.94 share on NYSE. The stock opened with a fall of % at $44.07 and touched an intraday high of $44.41, rising 0.50% against the last close of $44.19. The stock went to a low of $43.81 during the session.

Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-09-10$46.27$45.59$46.34$45.5120,801,502
2021-09-03$46.90$46.84$47.03$46.342,081,720,000
2021-09-02$46.48$46.84$46.87$46.132,614,940,000
2021-09-01$46.19$46.04$46.26$45.423,290,010,000
2021-08-31$46.72$46.07$47.14$45.933,453,260,000
2021-08-30$46.20$46.76$47.16$46.162,577,440,000
2021-08-27$47.37$46.60$47.50$46.533,287,440,000
2021-08-26$47.70$47.38$48.16$47.302,896,020,000
2021-08-25$48.04$47.51$48.28$46.935,098,630,000
2021-08-24$49.74$48.38$50.05$48.245,254,420,000
2021-08-23$50.29$49.93$51.36$49.608,852,740,000
Pfizer Inc.
235 East 42nd Street
New York, NY 10017
United States

http://www.pfizer.com
212 733 2323
Employees
78500
Sector
Healthcare
Sales or Revenue
55.52B
Industry
Drug Manufacturers - General
5Y Sales Change
-3.00
Fiscal Year Ends
2020-12-30

Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics, Inc, Merck KGaA, Valneva SE, and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam